This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): estradiol valerate/dienogest, BAY86-5027, SH T00658ID, Qlaira (EU)
Description: Natazia is a four-phasic oral contraceptive containing a combination of estradiol valerate, which is metabolized to estradiol, and the progestin dienogest. Natazia delivers varying doses of estradiol valerate, and the combination of estradiol valerate and dienogest on different days of the cycle.
Additional information available to subscribers only: